本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tevogen Bio Holdings

6.36
-0.0800-1.24%
盘前6.26-0.1000-1.57%08:56 EDT
成交量:1.20万
成交额:7.59万
市值:2,648.43万
市盈率:-0.79
高:6.81
开:6.81
低:6.15
收:6.44
52周最高:75.50
52周最低:4.14
股本:416.42万
流通股本:113.30万
量比:0.49
换手率:1.06%
股息:- -
股息率:- -
每股收益(TTM):-8.0804
每股收益(LYR):-3.5022
净资产收益率:--
总资产收益率:-416.53%
市净率:-1.55
市盈率(LYR):-1.82

数据加载中...

2025/04/18

重要事件披露

Form 8-K - Current report
2025/04/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/28

重要事件披露

Form 8-K - Current report
2024/11/19

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/26

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/08/23

重要事件披露

Form 8-K - Current report
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/01

SEC问询函

Form CORRESP - Correspondence
2024/07/31

SEC问询函

Form CORRESP - Correspondence
2024/07/29

SEC问询函

Form CORRESP - Correspondence
2024/07/23

SEC问询函

Form CORRESP - Correspondence
2024/07/23

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/22

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/22

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/06/08

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/30

重要事件披露

Form 8-K/A - Current report: [Amend]